Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus

Summary

This is a 36 months, randomized, double-blind, placebo-controlled, parallel-groups, equivalence multicenter trial in patients with inactive Systemic Lupus Erythematosus to evaluate if low disease activity can be sustained with withdrawal of glucocorticoids in patients on stable clinical remission or low disease activity.

Timeline

Start

2019-06

Primary completion

2022-06

Completion

2023-09

Drugs

Indications